AngioDynamics beat on sales and beat on earnings this morning -- sort of. The company reported a smaller-than-expected ...

Full Year 2025 Results Key Financial Results Revenue: US$292.5m (down 3.8% from FY ...

Fintel reports that on July 16, 2025, Lake Street initiated coverage of AngioDynamics (NasdaqGS:ANGO) with a Buy ...

The Motley Fool. DATE Tuesday, July 15, 2025 at 8:00 a.m. ET Read More: Earn up to $845 cash back this year just by changing ...

A Capital Region manufacturer expects to continue growing its revenue over the next year, though its bottom line could take a ...

Gain insights into AngioDynamics' Q4 2025 earnings, highlighting 12% revenue growth, international expansion, Med Tech advances, and a strong FY26 outlook.

(ANGO) on Tuesday reported a loss of $6.1 million in its fiscal fourth quarter. The Latham, New York-based company said it had a loss of ...

Analysts estimate that AngioDynamics will report an earnings per share (EPS) of $-0.12. Investors in AngioDynamics are eagerly awaiting the company's announcement, hoping for news of surpassing ...

QUEENSBURY -- Queensbury-based medical device manufacturer AngioDynamics Inc. said Tuesday afternoon it expects to be in its new headquarters building in Latham by early spring. The company ...

Medical technology company AngioDynamics Inc is bucking what it calls an "extraordinary" effort by a rival company to recover hundreds of thousands of dollars in legal costs following its win at ...